Quest Diagnostics, Inc. (DGX)
234.08
-5.07
(-2.12%)
USD |
NYSE |
Oct 16, 14:35
Quest Diagnostics SG&A Expense (TTM) : 2.038B for June 30, 2026
SG&A Expense (TTM) Chart
Historical SG&A Expense (TTM) Data
| Date | Value |
|---|---|
| June 30, 2026 | 2.038B |
| March 31, 2026 | 1.995B |
| December 31, 2025 | 1.967B |
| September 30, 2025 | 1.929B |
| June 30, 2025 | 1.876B |
| March 31, 2025 | 1.806B |
| December 31, 2024 | 1.77B |
| September 30, 2024 | 1.711B |
| June 30, 2024 | 1.643B |
| March 31, 2024 | 1.643B |
| December 31, 2023 | 1.642B |
| September 30, 2023 | 1.798B |
| June 30, 2023 | 1.882B |
| March 31, 2023 | 1.888B |
| December 31, 2022 | 1.874B |
| September 30, 2022 | 1.775B |
| June 30, 2022 | 1.738B |
| March 31, 2022 | 1.745B |
| December 31, 2021 | 1.727B |
| September 30, 2021 | 1.71B |
| June 30, 2021 | 1.679B |
| March 31, 2021 | 1.61B |
| December 31, 2020 | 1.55B |
| September 30, 2020 | 1.452B |
| June 30, 2020 | 1.418B |
| Date | Value |
|---|---|
| March 31, 2020 | 1.42B |
| December 31, 2019 | 1.457B |
| September 30, 2019 | 1.464B |
| June 30, 2019 | 1.456B |
| March 31, 2019 | 1.445B |
| December 31, 2018 | 1.424B |
| September 30, 2018 | 1.45B |
| June 30, 2018 | 1.444B |
| March 31, 2018 | 1.451B |
| December 31, 2017 | 1.443B |
| September 30, 2017 | 1.461B |
| June 30, 2017 | 1.522B |
| March 31, 2017 | 1.594B |
| December 31, 2016 | 1.681B |
| September 30, 2016 | 1.71B |
| June 30, 2016 | 1.703B |
| March 31, 2016 | 1.702B |
| December 31, 2015 | 1.679B |
| September 30, 2015 | 1.677B |
| June 30, 2015 | 1.721B |
| March 31, 2015 | 1.732B |
| December 31, 2014 | 1.728B |
| September 30, 2014 | 1.716B |
| June 30, 2014 | 1.693B |
| March 31, 2014 | 1.671B |
SG&A Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (TTM) Benchmarks
| Labcorp Holdings, Inc. | 2.219B |
| DaVita, Inc. | 1.732B |
| OPKO Health, Inc. | 205.85M |
| Psychemedics Corp. | -- |
| NeoGenomics, Inc. | 359.09M |